• PDF / 150,404 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 79 Downloads / 142 Views

DOWNLOAD

REPORT

---

1 S

Lack of efficacy: case report A Quasi experimental study conducted from January 2019 to June 2019 which included 255 patients described a 39-year-old man*, who experienced lack of efficacy following treatment with sofosbuvir and daclatasvir for hepatitis C. The man, who had hepatitis C, received oral sofosbuvir 400mg daily and oral daclatasvir 60mg daily for 12 weeks. However, he did not achieve sustained virologic response after 12 weeks of the treatment. * Identifying patient details (age and sex) have been obtained through direct communication with the author. Uddin Z, et al. Effectiveness of combination therapy with sofosbuvir and daclatasvir in HCV infected patients. Journal of Medical Sciences (Peshawar) 28: 239-243, No. 3, Jul 803519863 2020

0114-9954/20/1834-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

Reactions 12 Dec 2020 No. 1834